rs140781855

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000458.4(HNF1B):​c.1413C>T​(p.Pro471=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000611 in 1,552,674 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 6 hom. )

Consequence

HNF1B
NM_000458.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.18
Variant links:
Genes affected
HNF1B (HGNC:11630): (HNF1 homeobox B) This gene encodes a member of the homeodomain-containing superfamily of transcription factors. The protein binds to DNA as either a homodimer, or a heterodimer with the related protein hepatocyte nuclear factor 1-alpha. The gene has been shown to function in nephron development, and regulates development of the embryonic pancreas. Mutations in this gene result in renal cysts and diabetes syndrome and noninsulin-dependent diabetes mellitus, and expression of this gene is altered in some types of cancer. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 17-37701104-G-A is Benign according to our data. Variant chr17-37701104-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 36841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-37701104-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.18 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00278 (424/152256) while in subpopulation AFR AF= 0.00934 (388/41546). AF 95% confidence interval is 0.00857. There are 4 homozygotes in gnomad4. There are 199 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 424 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HNF1BNM_000458.4 linkuse as main transcriptc.1413C>T p.Pro471= synonymous_variant 7/9 ENST00000617811.5 NP_000449.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HNF1BENST00000617811.5 linkuse as main transcriptc.1413C>T p.Pro471= synonymous_variant 7/91 NM_000458.4 ENSP00000480291 P35680-1
HNF1BENST00000621123.4 linkuse as main transcriptc.1335C>T p.Pro445= synonymous_variant 7/91 ENSP00000482711 P1P35680-2
HNF1BENST00000613727.4 linkuse as main transcriptc.1261+3813C>T intron_variant 1 ENSP00000477524
HNF1BENST00000614313.4 linkuse as main transcriptc.1413C>T p.Pro471= synonymous_variant 7/85 ENSP00000482529

Frequencies

GnomAD3 genomes
AF:
0.00279
AC:
424
AN:
152138
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00937
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.000671
AC:
107
AN:
159492
Hom.:
1
AF XY:
0.000441
AC XY:
37
AN XY:
83942
show subpopulations
Gnomad AFR exome
AF:
0.00898
Gnomad AMR exome
AF:
0.000600
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000145
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.000375
AC:
525
AN:
1400418
Hom.:
6
Cov.:
32
AF XY:
0.000321
AC XY:
222
AN XY:
690896
show subpopulations
Gnomad4 AFR exome
AF:
0.0106
Gnomad4 AMR exome
AF:
0.000612
Gnomad4 ASJ exome
AF:
0.0000397
Gnomad4 EAS exome
AF:
0.0000554
Gnomad4 SAS exome
AF:
0.0000378
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000889
Gnomad4 OTH exome
AF:
0.000965
GnomAD4 genome
AF:
0.00278
AC:
424
AN:
152256
Hom.:
4
Cov.:
32
AF XY:
0.00267
AC XY:
199
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.00934
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00106
Hom.:
1
Bravo
AF:
0.00315

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 28, 2020- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 19, 2024- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 19, 2016- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 31, 2020- -
Maturity onset diabetes mellitus in young Benign:2
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-HNF1B gene mutations are associated with early onset diabetes and pancreatic atrophy. It is also associated with multiple renal manifestations including renal cysts, Tubulointerstitial disease, glomerulocystic disease, renal hypoplasia, hypomagnesemia.However no sufficient evidence is found to ascertain the role of this particular variant rs140781855, yet. -
Renal cysts and diabetes syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testing;curationWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 18, 2011- -
HNF1B-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 03, 2022This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Nonpapillary renal cell carcinoma Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
3.8
DANN
Benign
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140781855; hg19: chr17-36061109; API